Corient Private Wealth’s Bruker BRKR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-3,430
Closed -$237K 2380
2024
Q3
$237K Sell
3,430
-310
-8% -$20K ﹤0.01% 2135
2024
Q2
$239K Sell
3,740
-155
-4% -$11.7K ﹤0.01% 2029
2024
Q1
$366K Buy
3,895
+42
+1% +$3.38K ﹤0.01% 1787
2023
Q4
$283K Buy
3,853
+419
+12% +$26.8K ﹤0.01% 1888
2023
Q3
$215K Sell
3,434
-321
-9% -$21.6K ﹤0.01% 1886
2023
Q2
$278K Buy
3,755
+489
+15% +$37.3K ﹤0.01% 1737
2023
Q1
$257K Buy
3,266
+72
+2% +$5.2K ﹤0.01% 1677
2022
Q4
$218K Buy
+3,194
New +$203K ﹤0.01% 1459

Other funds holding BRKR

Corient Private Wealth's BRKR Position: Q4 2024 in Review

Corient Private Wealth sold out of Bruker (BRKR) in Q4 2024, closing a stake of 3,430 shares — an estimated $237K sold.

Corient Private Wealth first reported a position in BRKR in Q4 2022 and held it in 8 quarters. The position peaked at $366K in Q1 2024. 367 funds tracked by Wall St. Rank hold BRKR as of Q4 2024.

  • Corient Private Wealth reported no remaining Bruker position as of Q4 2024 after selling out during the quarter.
  • Corient Private Wealth sold 3,430 Bruker shares in Q4 2024, an estimated $237K.
  • Corient Private Wealth first reported a position in Bruker in Q4 2022 and held it in 8 quarters.
  • Corient Private Wealth's Bruker position peaked at $366K in Q1 2024.
  • 367 funds tracked by Wall St. Rank held Bruker as of Q4 2024.

Based on Corient Private Wealth's 13F filing for Q4 2024, filed 10 Feb 2025.